Heart Failure Pathway & TRPV1 Inhibition: Mechanism and Therapeutic Potential #3480774 (License: Personal Use)

The diagram outlines the pathological cascade beginning with conditions like ischemic heart disease, valvular dysfunction, or hypertension, which trigger left ventricular hypertrophy, then dilation, ultimately culminating in heart failure and death. A green arrow indicates that pharmacological inhibition of the TRPV1 ion channel can interrupt this progression, offering cardioprotection. Each stage is depicted with anatomically accurate heart illustrations showing progressive chamber enlargement and wall thickening.

Used in cardiology educational resources, research summaries, or drug development pages targeting clinicians, researchers, or patients seeking mechanistic understanding of heart failure and emerging therapies. Matches user intent for learning about molecular targets in cardiovascular disease.